178 related articles for article (PubMed ID: 34815381)
21. The E3 ubiquitin-ligase HACE1 catalyzes the ubiquitylation of active Rac1.
Torrino S; Visvikis O; Doye A; Boyer L; Stefani C; Munro P; Bertoglio J; Gacon G; Mettouchi A; Lemichez E
Dev Cell; 2011 Nov; 21(5):959-65. PubMed ID: 22036506
[TBL] [Abstract][Full Text] [Related]
22. Nrf2 Expressions Correlate with WHO Grades in Gliomas and Meningiomas.
Tsai WC; Hueng DY; Lin CR; Yang TC; Gao HW
Int J Mol Sci; 2016 May; 17(5):. PubMed ID: 27187376
[TBL] [Abstract][Full Text] [Related]
23. Regulation of the Nrf2-Keap1 antioxidant response by the ubiquitin proteasome system: an insight into cullin-ring ubiquitin ligases.
Villeneuve NF; Lau A; Zhang DD
Antioxid Redox Signal; 2010 Dec; 13(11):1699-712. PubMed ID: 20486766
[TBL] [Abstract][Full Text] [Related]
24. Bardoxolone ameliorates TGF-β1-associated renal fibrosis through Nrf2/Smad7 elevation.
Song MK; Lee JH; Ryoo IG; Lee SH; Ku SK; Kwak MK
Free Radic Biol Med; 2019 Jul; 138():33-42. PubMed ID: 31059771
[TBL] [Abstract][Full Text] [Related]
25. Overexpression of ubiquitin-specific protease 2a (USP2a) and nuclear factor erythroid 2-related factor 2 (Nrf2) in human gliomas.
Boustani MR; Khoshnood RJ; Nikpasand F; Taleshi Z; Ahmadi K; Yahaghi E; Goudarzi PK
J Neurol Sci; 2016 Apr; 363():249-52. PubMed ID: 27000259
[TBL] [Abstract][Full Text] [Related]
26. TRIM11 is overexpressed in high-grade gliomas and promotes proliferation, invasion, migration and glial tumor growth.
Di K; Linskey ME; Bota DA
Oncogene; 2013 Oct; 32(42):5038-47. PubMed ID: 23178488
[TBL] [Abstract][Full Text] [Related]
27. Overexpression of Nrf2 attenuates Carmustine-induced cytotoxicity in U87MG human glioma cells.
Sukumari-Ramesh S; Prasad N; Alleyne CH; Vender JR; Dhandapani KM
BMC Cancer; 2015 Mar; 15():118. PubMed ID: 25851054
[TBL] [Abstract][Full Text] [Related]
28. Tumor-suppressive role of HACE1 in hepatocellular carcinoma and its clinical significance.
Gao ZF; Wu YN; Bai ZT; Zhang L; Zhou Q; Li X
Oncol Rep; 2016 Dec; 36(6):3427-3435. PubMed ID: 27805249
[TBL] [Abstract][Full Text] [Related]
29. Hrd1 suppresses Nrf2-mediated cellular protection during liver cirrhosis.
Wu T; Zhao F; Gao B; Tan C; Yagishita N; Nakajima T; Wong PK; Chapman E; Fang D; Zhang DD
Genes Dev; 2014 Apr; 28(7):708-22. PubMed ID: 24636985
[TBL] [Abstract][Full Text] [Related]
30. Aberrant methylation of the HACE1 gene is frequently detected in advanced colorectal cancer.
Hibi K; Sakata M; Sakuraba K; Shirahata A; Goto T; Mizukami H; Saito M; Ishibashi K; Kigawa G; Nemoto H; Sanada Y
Anticancer Res; 2008; 28(3A):1581-4. PubMed ID: 18630515
[TBL] [Abstract][Full Text] [Related]
31. PIDD interaction with KEAP1 as a new mutation-independent mechanism to promote NRF2 stabilization and chemoresistance in NSCLC.
Ji L; Zhang R; Chen J; Xue Q; Moghal N; Tsao MS
Sci Rep; 2019 Aug; 9(1):12437. PubMed ID: 31455821
[TBL] [Abstract][Full Text] [Related]
32. The E3 ligase HACE1 is a critical chromosome 6q21 tumor suppressor involved in multiple cancers.
Zhang L; Anglesio MS; O'Sullivan M; Zhang F; Yang G; Sarao R; Mai PN; Cronin S; Hara H; Melnyk N; Li L; Wada T; Liu PP; Farrar J; Arceci RJ; Sorensen PH; Penninger JM
Nat Med; 2007 Sep; 13(9):1060-9. PubMed ID: 17694067
[TBL] [Abstract][Full Text] [Related]
33. Knockdown of nuclear factor erythroid 2-related factor 2 by lentivirus induces differentiation of glioma stem-like cells.
Zhu J; Wang H; Fan Y; Hu Y; Ji X; Sun Q; Liu H
Oncol Rep; 2014 Sep; 32(3):1170-8. PubMed ID: 25017049
[TBL] [Abstract][Full Text] [Related]
34. HACE1 is a tumor suppressor gene candidate in natural killer cell neoplasms.
Küçük C; Hu X; Iqbal J; Gaulard P; Klinkebiel D; Cornish A; Dave BJ; Chan WC
Am J Pathol; 2013 Jan; 182(1):49-55. PubMed ID: 23142381
[TBL] [Abstract][Full Text] [Related]
35. Keap1-Nrf2 Interaction Suppresses Cell Motility in Lung Adenocarcinomas by Targeting the S100P Protein.
Chien MH; Lee WJ; Hsieh FK; Li CF; Cheng TY; Wang MY; Chen JS; Chow JM; Jan YH; Hsiao M; Hua KT; Kuo ML
Clin Cancer Res; 2015 Oct; 21(20):4719-32. PubMed ID: 26078391
[TBL] [Abstract][Full Text] [Related]
36. Uncovering and deciphering the pro-invasive role of HACE1 in melanoma cells.
El-Hachem N; Habel N; Naiken T; Bzioueche H; Cheli Y; Beranger GE; Jaune E; Rouaud F; Nottet N; Reinier F; Gaudel C; Colosetti P; Bertolotto C; Ballotti R
Cell Death Differ; 2018 Nov; 25(11):2010-2022. PubMed ID: 29515254
[TBL] [Abstract][Full Text] [Related]
37. Loss of the E3 ubiquitin ligase HACE1 results in enhanced Rac1 signaling contributing to breast cancer progression.
Goka ET; Lippman ME
Oncogene; 2015 Oct; 34(42):5395-405. PubMed ID: 25659579
[TBL] [Abstract][Full Text] [Related]
38. Unique pattern of component gene disruption in the NRF2 inhibitor KEAP1/CUL3/RBX1 E3-ubiquitin ligase complex in serous ovarian cancer.
Martinez VD; Vucic EA; Thu KL; Pikor LA; Hubaux R; Lam WL
Biomed Res Int; 2014; 2014():159459. PubMed ID: 25114896
[TBL] [Abstract][Full Text] [Related]
39. Carboxyl terminus of Hsp70-interacting protein (CHIP) contributes to human glioma oncogenesis.
Xu T; Zhou Q; Zhou J; Huang Y; Yan Y; Li W; Wang C; Hu G; Lu Y; Chen J
Cancer Sci; 2011 May; 102(5):959-66. PubMed ID: 21272160
[TBL] [Abstract][Full Text] [Related]
40. HACE1 is a putative tumor suppressor gene in B-cell lymphomagenesis and is down-regulated by both deletion and epigenetic alterations.
Bouzelfen A; Alcantara M; Kora H; Picquenot JM; Bertrand P; Cornic M; Mareschal S; Bohers E; Maingonnat C; Ruminy P; Adriouch S; Boyer O; Dubois S; Bastard C; Tilly H; Latouche JB; Jardin F
Leuk Res; 2016 Jun; 45():90-100. PubMed ID: 27107267
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
